Pioglitazone lowers postload glucose and enhances composite insulin sensitivity index during oral glucose tolerance test compared with metformin or gliclazide in patients (pts) with Type 2 diabetes

被引：0
|
作者：
Tan, M
Johns, D
Ceriello, A
Widel, M
Gilmore, K
Eckland, D
机构：
[1] Eli Lilly & Co, Diabet Prod Team, Indianapolis, IN 46285 USA
[2] Univ Udine, Dept Pathol & Med, I-33100 Udine, Italy
[3] Takeda Europe, R&D Ctr Ltd, London, England
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
718
引用
收藏
页码：A259 / A260
页数：2
相关论文
共 50 条
  • [1] Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes
    Ceriello, A
    Eckland, DJ
    Johns, D
    Gilmore, KJ
    Widel, M
    Tan, MH
    DIABETES CARE, 2005, 28 (02) : 266 - 272
  • [2] Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes (vol 28, pg 266, 2005)
    Ceriello, A
    Johns, D
    Widel, M
    Eckland, DJ
    Gilmore, KJ
    Tan, MH
    DIABETES CARE, 2005, 28 (05) : 1272 - 1272
  • [3] A new index of insulin sensitivity obtained from the oral glucose tolerance test applicable to advanced type 2 diabetes
    Kanauchi, M
    DIABETES CARE, 2002, 25 (10) : 1891 - 1892
  • [4] Delay in glucose peak time during the oral glucose tolerance test as an indicator of insulin resistance and insulin secretion in type 2 diabetes patients
    Wang, Xinlei
    Zhao, Xiaoqin
    Zhou, Ranran
    Gu, Yunjuan
    Zhu, Xiaohui
    Tang, Zhuqi
    Yuan, Xinlu
    Chen, Wei
    Zhang, Rongping
    Qian, Chen
    Cui, Shiwei
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (06) : 1288 - 1295
  • [5] New insulin sensitivity index from the oral glucose tolerance test
    Kazama, Youichiro
    Takamura, Toshinari
    Sakurai, Masaru
    Shindo, Hisakazu
    Ohkubo, Eizho
    Aida, Kaoru
    Harii, Norikazu
    Taki, Katsumi
    Kaneshige, Masahiro
    Tanaka, Shoichiro
    Shimura, Hiroki
    Endo, Toyoshi
    Kobayashi, Tetsuro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) : 24 - 30
  • [6] 2-Year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with Type 2 diabetes
    Seufert, Jochen
    Urquhart, Richard
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (03) : 453 - 460
  • [7] Red wine enhances glucose-dependent insulinotropic peptide (GIP) and insulin responses in type 2 diabetes during an oral glucose tolerance test
    Abraham K.A.
    Kearney M.L.
    Reynolds L.J.
    Thyfault J.P.
    Diabetology International, 2016, 7 (2) : 173 - 180
  • [8] Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type 2 Diabetes
    Yanqiu Jiang
    Shiwei Cui
    Rongping Zhang
    Xiaoqin Zhao
    Lili Yao
    Rong OuYang
    Wei Chen
    Ranran Zhou
    Xuying Zhao
    Zhuqi Tang
    Jin Yuan
    Jie Yuan
    Chen Qian
    Ping Huang
    Yunjuan Gu
    Xinlei Wang
    Diabetes Therapy, 2021, 12 : 2437 - 2450
  • [9] Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type 2 Diabetes
    Jiang, Yanqiu
    Cui, Shiwei
    Zhang, Rongping
    Zhao, Xiaoqin
    Yao, Lili
    OuYang, Rong
    Chen, Wei
    Zhou, Ranran
    Zhao, Xuying
    Tang, Zhuqi
    Yuan, Jin
    Yuan, Jie
    Qian, Chen
    Huang, Ping
    Gu, Yunjuan
    Wang, Xinlei
    DIABETES THERAPY, 2021, 12 (09) : 2437 - 2450
  • [10] Novel insulin sensitivity index derived from oral glucose tolerance test
    Soonthornpun, S
    Setasuban, W
    Thamprasit, A
    Chayanunnukul, W
    Rattarasarn, C
    Geater, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03): : 1019 - 1023
12345